LEO LABORATORIES LIMITED

🇮🇪Ireland
Ownership
-
Employees
-
Market Cap
-
Website

A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face

First Posted Date
2006-12-06
Last Posted Date
2023-06-09
Lead Sponsor
LEO Pharma
Target Recruit Count
48
Registration Number
NCT00408330

LEO19123 Cream in the Treatment of Hand Eczema

Phase 2
Completed
Conditions
First Posted Date
2006-11-28
Last Posted Date
2007-08-03
Lead Sponsor
LEO Pharma
Target Recruit Count
75
Registration Number
NCT00404196
Locations
🇬🇧

Queen's Medical Centre, Nottingham, United Kingdom

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis

First Posted Date
2006-11-27
Last Posted Date
2023-06-09
Lead Sponsor
LEO Pharma
Target Recruit Count
48
Registration Number
NCT00403949

LEO19123 Cream in the Treatment of Atopic Dermatitis

Phase 2
Completed
Conditions
First Posted Date
2006-10-25
Last Posted Date
2008-04-30
Lead Sponsor
LEO Pharma
Target Recruit Count
75
Registration Number
NCT00392067
Locations
🇬🇧

Manchester Royal Infirmary, Manchester, United Kingdom

🇨🇦

Clinique Dermatologique Maizerets, Quebec City, Quebec, Canada

🇫🇮

Helsinki University Central Hospital, Helsinki, Finland

and more 1 locations

Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis

Phase 3
Completed
Conditions
First Posted Date
2006-01-19
Last Posted Date
2015-03-26
Lead Sponsor
LEO Pharma
Target Recruit Count
160
Registration Number
NCT00279162
Locations
🇺🇸

Center for Clinical Studies, Houston, Texas, United States

Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

Phase 4
Completed
Conditions
Interventions
First Posted Date
2006-01-16
Last Posted Date
2019-03-15
Lead Sponsor
LEO Pharma
Target Recruit Count
541
Registration Number
NCT00277394
Locations
🇫🇷

Hôpital de la Cavale Blanche, Brest, France

🇧🇬

Bulgaria - managed by CRO, Sofia, Bulgaria

🇨🇿

Czech Republic - managed by CRO, Praha, Czechia

and more 6 locations

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris

Phase 2
Completed
Conditions
First Posted Date
2005-12-09
Last Posted Date
2015-03-26
Lead Sponsor
LEO Pharma
Target Recruit Count
360
Registration Number
NCT00263718
Locations
🇸🇪

Läkarhuset Vällingby, Vällingby, Sweden

🇩🇪

Universitätsklinikum Leipzig, Leipzig, Germany

🇮🇪

Waterford Regional Hospital, Waterford, Ireland

and more 2 locations

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris

Phase 4
Completed
Conditions
First Posted Date
2005-11-04
Last Posted Date
2008-02-21
Lead Sponsor
LEO Pharma
Target Recruit Count
320
Registration Number
NCT00248456
Locations
🇨🇳

Fudan University First Hospital, Dermatology Department, Shanghai, China

Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis

Phase 3
Completed
Conditions
First Posted Date
2005-10-24
Last Posted Date
2015-03-26
Lead Sponsor
LEO Pharma
Target Recruit Count
300
Registration Number
NCT00243464
Locations
🇧🇪

Universitair Ziekenhuis Sint Raphaël, Dienst Dermatologie, Leuven, Belgium

🇨🇦

Windsor Clinical Research Inc., Windsor, Ontario, Canada

🇩🇰

Department of Dermatology, Marselisborg Centres, Aarhus, Denmark

and more 2 locations

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis

Phase 3
Completed
Conditions
First Posted Date
2005-09-22
Last Posted Date
2015-03-26
Lead Sponsor
LEO Pharma
Target Recruit Count
1350
Registration Number
NCT00216840
Locations
🇩🇪

Georg-August-Universität Göttingen, Abteilung Dermatologie und Venerologie, Göttingen, Germany

🇬🇧

Royal Gwent Hospital, Department of Dermatology, Newport, United Kingdom

🇫🇮

Policlinic of Dermatology, Medical Reception Centre, Turku, Finland

and more 4 locations
© Copyright 2024. All Rights Reserved by MedPath